牛牛AI助理已提取核心訊息
60 Degrees Pharmaceuticals, Inc. has announced an increase in the maximum aggregate gross sales price of shares available under its At the Market Issuance Sales Agreement with WallachBeth Capital LLC to $2,295,192. This update, filed on August 2, 2024, amends previous prospectus supplements and the base prospectus, reflecting the increased offering size from the initial registration of $1,253,603. As of the filing date, the company has sold 8,133,821 shares for a total of $1,994,583.43. The common stock is traded on The Nasdaq Capital Market under the symbol 'SXTP.' The company's outstanding common stock held by non-affiliates is valued at approximately $6,885,578, based on the closing sale price on June 10, 2024. 60 Degrees Pharmaceuticals emphasizes that investing in its common stock carries significant risks, as detailed in the 'Risk Factors' section of the prospectus supplements and documents filed with the SEC.
60 Degrees Pharmaceuticals, Inc. has announced an increase in the maximum aggregate gross sales price of shares available under its At the Market Issuance Sales Agreement with WallachBeth Capital LLC to $2,295,192. This update, filed on August 2, 2024, amends previous prospectus supplements and the base prospectus, reflecting the increased offering size from the initial registration of $1,253,603. As of the filing date, the company has sold 8,133,821 shares for a total of $1,994,583.43. The common stock is traded on The Nasdaq Capital Market under the symbol 'SXTP.' The company's outstanding common stock held by non-affiliates is valued at approximately $6,885,578, based on the closing sale price on June 10, 2024. 60 Degrees Pharmaceuticals emphasizes that investing in its common stock carries significant risks, as detailed in the 'Risk Factors' section of the prospectus supplements and documents filed with the SEC.
60度製藥公司宣佈，其與WallachBeth Capital LLC的現場銷售協議下可售股票的最大總契約總價已增加至229萬5192美元。這個更新於2024年8月2日提交，修改了之前的招股說明書補充和基礎招股說明書，反映了從最初註冊的125萬3603美元到增加的發行量。截至提交日期，公司已出售8133821股，總價值1994583.43美元。其普通股在納斯達克資本市場上交易，標的爲’SXTP‘。截至2024年6月10日收盤價，公司持有非關聯方的普通股價值約爲6885578美元。60度製藥強調，投資其普通股存在重大風險，其中詳細解釋在招股說明書補充和提交給SEC的文件的’風險因素‘一章中。
60度製藥公司宣佈，其與WallachBeth Capital LLC的現場銷售協議下可售股票的最大總契約總價已增加至229萬5192美元。這個更新於2024年8月2日提交，修改了之前的招股說明書補充和基礎招股說明書，反映了從最初註冊的125萬3603美元到增加的發行量。截至提交日期，公司已出售8133821股，總價值1994583.43美元。其普通股在納斯達克資本市場上交易，標的爲’SXTP‘。截至2024年6月10日收盤價，公司持有非關聯方的普通股價值約爲6885578美元。60度製藥強調，投資其普通股存在重大風險，其中詳細解釋在招股說明書補充和提交給SEC的文件的’風險因素‘一章中。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了